These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 9763348)

  • 1. Laboratory diagnosis of hereditary thrombophilia.
    Michiels JJ; Hamulyák K
    Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein C pathway (PCP) screening test for the detection of APC resistance and protein C or S deficiencies.
    Haas FJ; van Sterkenburg-Kamp BM; Scheepers HA
    Semin Thromb Hemost; 1998; 24(4):355-62. PubMed ID: 9763352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital protein S deficiencies; diagnostic difficulties].
    Guermazi S; Conard J
    Pathol Biol (Paris); 2009 Sep; 57(6):483-7. PubMed ID: 18583066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
    Schöni R; Quehenberger P; Wu JR; Wilmer M
    Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
    Eid SS
    Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of thrombophilia]].
    Kemkes-Matthes B
    Zentralbl Chir; 2001 Jun; 126(6):433-7. PubMed ID: 11446062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary disorders of the protein C system in central artery and branch arteriolar occlusions].
    Greiner K; Hafner G; Prellwitz W; Pfeiffer N
    Klin Monbl Augenheilkd; 1999 Jul; 215(1):33-6. PubMed ID: 10448635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
    Toulon P
    Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
    Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
    Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro CR global: an effective screening test for thrombophilia.
    Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
    Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
    Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
    Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.